Cadila Pharmaceuticals launches Vasograin Plus for treatment of migraines
Vasograin Plus represents a major advancement in the treatment of migraine
Vasograin Plus represents a major advancement in the treatment of migraine
Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Subscribe To Our Newsletter & Stay Updated